105 related articles for article (PubMed ID: 1550082)
41. Induction therapy of newly diagnosed acute nonlymphocytic leukemia with idarubicin and cytosine arabinoside--the Taiwan experience.
Chen YC; Lin SF; Yao M; Chen TY; Tsao CJ; Chen TP
Semin Hematol; 1996 Oct; 33(4 Suppl 3):30-4. PubMed ID: 8916314
[TBL] [Abstract][Full Text] [Related]
42. [The continuous-DCMP therapy for acute nonlymphocytic leukemia in elderly patients--comparison with younger patients].
Ito T; Yamamoto K; Kinoshita T; Sugiura I; Saito M; Ono Y; Hayashi K; Nagata K; Kamiya O; Ohara K
Rinsho Ketsueki; 1989 Apr; 30(4):421-8. PubMed ID: 2769965
[TBL] [Abstract][Full Text] [Related]
43. Etoposide in leukemia.
Bishop JF; Lowethal R; Joshua D; Matthews JP; Wolf MM; Cooper IA
Cancer; 1991 Jan; 67(1 Suppl):285-91. PubMed ID: 1984829
[TBL] [Abstract][Full Text] [Related]
44. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
[TBL] [Abstract][Full Text] [Related]
45. Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia.
Colovic N; Tomin D; Vidovic A; Suvajdzic N; Jankovic G; Palibrk V; Djunic I; Djurasinovic V; Virijevic M
Biomed Pharmacother; 2012 Dec; 66(8):578-82. PubMed ID: 23085253
[TBL] [Abstract][Full Text] [Related]
46. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
Esumi N; Todo S; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
[TBL] [Abstract][Full Text] [Related]
47. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
[TBL] [Abstract][Full Text] [Related]
48. Acute myeloid leukemia in the elderly: etoposide when anthracyclins are contraindicated.
Chaoui D; Peffault De Latour R; Legrand O; Marie JP
Leuk Lymphoma; 2005 Mar; 46(3):401-4. PubMed ID: 15621830
[TBL] [Abstract][Full Text] [Related]
49. Outcome of acute myeloid leukaemia in adults: a retrospective analysis.
Saikia TK; Bakshi A; Bhagwat R; Tawde S; Nair R; Nair CN; Parikh PM
Natl Med J India; 2005; 18(1):12-5. PubMed ID: 15835484
[TBL] [Abstract][Full Text] [Related]
50. High-dose cytosine arabinoside and L-asparaginase therapy for poor-risk adult acute nonlymphocytic leukemia. A retrospective study.
Evans C; Winkelstein A; Rosenfeld CS; Zeigler ZR; Shadduck RK
Cancer; 1990 Jun; 65(12):2624-30. PubMed ID: 2340464
[TBL] [Abstract][Full Text] [Related]
51. Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patients.
Staib P; Lathan B; Knöppel-Schwark S; Tesch H; Voliotis D; Steinmetz HT; Schwonzen M; Wickramanayake PD; Diehl V
Ann Oncol; 1998 Feb; 9(2):221-3. PubMed ID: 9553670
[TBL] [Abstract][Full Text] [Related]
52. Combined etoposide and 5-azacitidine in children and adolescents with refractory or relapsed acute nonlymphocytic leukemia: a Pediatric Oncology Group Study.
Hakami N; Look AT; Steuber PC; Krischer J; Castleberry R; Harris R; Ravindranath Y; Vietti TJ
J Clin Oncol; 1987 Jul; 5(7):1022-5. PubMed ID: 2439659
[TBL] [Abstract][Full Text] [Related]
53. Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia.
Amadori S; Arcese W; Isacchi G; Meloni G; Petti MC; Monarca B; Testi AM; Mandelli F
J Clin Oncol; 1991 Jul; 9(7):1210-4. PubMed ID: 2045861
[TBL] [Abstract][Full Text] [Related]
54. Etoposide in the management of leukemia: a review.
Bishop JF
Semin Oncol; 1991 Feb; 18(1 Suppl 2):62-9. PubMed ID: 1992536
[TBL] [Abstract][Full Text] [Related]
55. Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204.
Amadori S; Ceci A; Comelli A; Madon E; Masera G; Nespoli L; Paolucci G; Zanesco L; Covelli A; Mandelli F
J Clin Oncol; 1987 Sep; 5(9):1356-63. PubMed ID: 3476689
[TBL] [Abstract][Full Text] [Related]
56. [Effect of etoposide added to individualized induction therapy of adult acute myeloid leukemia--the JALSG-AML-92 Study. Japan Adult Leukemia Study Group].
Miyawaki S; Tanimoto M; Kobayashi T; Minami S; Tamura J; Omoto E; Kuriyama K; Hatake K; Saito K; Ohno R
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1160-7. PubMed ID: 10945011
[TBL] [Abstract][Full Text] [Related]
57. Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant disease.
Roberts MM; Juttner CA; To LB; Kimber RJ
Leuk Res; 1988; 12(10):817-21. PubMed ID: 3199841
[TBL] [Abstract][Full Text] [Related]
58. [Results of induction treatment with idarubicin for acute nonlymphoblastic leukemia in adults].
Hołowiecki J; Krzemień S; Rudzka E; Krawczyk M; Wojnar J; Hołowiecka B; Wacławik A; Wojciechowska M; Kachel L; Cedrych I
Acta Haematol Pol; 1994; 25(3):221-30. PubMed ID: 7992594
[TBL] [Abstract][Full Text] [Related]
59. Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).
Cassileth PA; Lee SJ; Litzow MR; Miller KB; Stadtmauer EA; Tallman MS; Lazarus HM; Bennett JM; Paietta E; Dewald GW; Rowe JM;
Leuk Lymphoma; 2005 Jan; 46(1):55-61. PubMed ID: 15621781
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of myeloperoxidase containing blast cells in acute myelogenous leukaemia.
Advani SH; Hegde UP; Iyer RS; Gopal R; Saikia TK; Pai SK; Nair CN; Kurkure PA; Pai VR; Nadkarni KS
Indian J Med Res; 1993 Feb; 98():8-14. PubMed ID: 8388366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
